INCY Incyte
Nasdaq · SEC CIK 879169 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $58.34M 30 sales by 10 insiders
- Filings on record
- 440 since 2021-07-02, latest 2026-09-24 16:06
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Hoppenot Herve | Dir | — | $19.77M |
| CAGNONI PABLO J | Pres, R, D | — | $14.10M |
| Stein Steven H | EVP, Chief Medical Off | — | $7.86M |
| Mayes Patrick A | EVP, CSO | — | $6.56M |
| Morrissey Michael James | EVP, Head of Tech. Ops | — | $5.68M |
| Clancy Paul J | Dir | — | $1.42M |
| Issa Mohamed Khairie | EVP, Head of US Oncology | — | $1.31M |
| Tray Thomas | Principal Accounting Off | — | $879.0K |
| Denton Sheila A. | EVP, GC | — | $465.2K |
| Heeson Lee | EVP, Head of Incyte Intl | — | $289.0K |
Transactions 497
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-24 16:06 | 2026-09-22 | INCY | Gardner David H | EVP, Chief Strategy Off | F - Tax | $126.93 | -920 | 15.9K | -5% | -$116.8K | |
| DMT | 2026-09-17 16:04 | 2026-09-15 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | M - OptEx | $66.39 | +23.2K | 206.4K | +13% | +$1.54M |
| DMT | 2026-09-17 16:04 | 2026-09-15 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | S - Sale+OE | $120.49 | -23.2K | 183.2K | -11% | -$2.80M |
| 2026-08-27 16:07 | 2026-08-25 | INCY | Basi Ramitpal K | EVP, Human Resources | F - Tax | $129.72 | -504 | 11.0K | -4% | -$65.4K | |
| T | 2026-08-20 17:15 | 2026-08-19 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | S - Sale | $125.56 | -10.8K | 183.2K | -6% | -$1.36M |
| T | 2026-08-14 16:01 | 2026-08-12 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | S - Sale | $120.04 | -10.8K | 194.0K | -5% | -$1.30M |
| T | 2026-08-07 16:02 | 2026-08-05 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | S - Sale | $122.69 | -10.6K | 204.8K | -5% | -$1.31M |
| DT | 2026-08-07 16:01 | 2026-08-05 | INCY | Mayes Patrick A | EVP, CSO | M - OptEx | $106.47 | +2,207 | 63.6K | +4% | +$235.0K |
| DT | 2026-08-07 16:01 | 2026-08-05 | INCY | Mayes Patrick A | EVP, CSO | S - Sale+OE | $123.99 | -2,207 | 61.4K | -3% | -$273.6K |
| T | 2026-08-04 16:04 | 2026-07-31 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | S - Sale | $119.70 | -15.9K | 215.4K | -7% | -$1.90M |
| DMT | 2026-08-04 16:04 | 2026-07-31+ | INCY | Mayes Patrick A | EVP, CSO | M - OptEx | $78.48 | +45.8K | 67.5K | +211% | +$3.59M |
| DMT | 2026-08-04 16:04 | 2026-07-31+ | INCY | Mayes Patrick A | EVP, CSO | S - Sale+OE | $119.58 | -48.0K | 61.4K | -44% | -$5.73M |
| D | 2026-07-20 16:10 | 2026-07-16 | INCY | Tray Thomas | Principal Accounting Off | A - Grant | $0.00 | +2,834 | 21.7K | +15% | $0 |
| DT | 2026-07-20 16:10 | 2026-07-16 | INCY | Stein Steven H | CMO, Head of Late-Stage Dev | S - Sale | $114.73 | -1,877 | 21.1K | -8% | -$215.3K |
| DT | 2026-07-20 16:10 | 2026-07-16 | INCY | Stein Steven H | CMO, Head of Late-Stage Dev | A - Grant | $0.00 | +9,798 | 30.9K | +46% | $0 |
| D | 2026-07-20 16:10 | 2026-07-16 | INCY | Mayes Patrick A | EVP, CSO | A - Grant | $0.00 | +5,916 | 63.6K | +10% | $0 |
| D | 2026-07-20 16:09 | 2026-07-16 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | A - Grant | $0.00 | +13.4K | 231.3K | +6% | $0 |
| DT | 2026-07-20 16:09 | 2026-07-16 | INCY | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | S - Sale | $115.01 | -1,093 | 63.9K | -2% | -$125.7K |
| DT | 2026-07-20 16:09 | 2026-07-16 | INCY | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | A - Grant | $0.00 | +7,857 | 71.8K | +12% | $0 |
| D | 2026-07-20 16:08 | 2026-07-16 | INCY | Basi Ramitpal K | EVP, Human Resources | A - Grant | $0.00 | +4,991 | 11.5K | +77% | $0 |
| D | 2026-07-20 16:08 | 2026-07-16 | INCY | Gardner David H | EVP, Chief Strategy Off | A - Grant | $0.00 | +7,395 | 16.8K | +78% | $0 |
| D | 2026-07-20 16:08 | 2026-07-16 | INCY | Hoffman Richard A. | EVP, GC | A - Grant | $0.00 | +7,395 | 16.9K | +78% | $0 |
| D | 2026-07-20 16:07 | 2026-07-16 | INCY | Meury William | CEO, Dir | A - Grant | $0.00 | +26.8K | 183.1K | +17% | $0 |
| M | 2026-07-16 16:08 | 2026-07-14+ | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | F - Tax | $114.93 | -22.9K | 217.9K | -10% | -$2.63M |
| M | 2026-07-16 16:07 | 2026-07-14+ | INCY | Mayes Patrick A | EVP, CSO | F - Tax | $115.04 | -1,949 | 57.7K | -3% | -$224.2K |
| M | 2026-07-16 16:07 | 2026-07-14+ | INCY | Tray Thomas | Principal Accounting Off | F - Tax | $115.01 | -1,790 | 18.9K | -9% | -$205.9K |
| MT | 2026-07-16 16:07 | 2026-07-14+ | INCY | Stein Steven H | CMO, Head of Late-Stage Dev | F - Tax | $114.91 | -24.9K | 23.0K | -52% | -$2.86M |
| T | 2026-07-16 16:07 | 2026-07-15 | INCY | Stein Steven H | CMO, Head of Late-Stage Dev | S - Sale | $113.05 | -28.2K | 26.1K | -52% | -$3.19M |
| 2026-07-16 16:06 | 2026-07-15 | INCY | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | F - Tax | $115.09 | -1,099 | 65.0K | -2% | -$126.5K | |
| 2026-07-07 16:10 | 2026-07-02 | INCY | Mayes Patrick A | EVP, CSO | F - Tax | $116.86 | -350 | 59.7K | -0.6% | -$40.9K | |
| 2026-07-07 16:09 | 2026-07-02 | INCY | Tray Thomas | Principal Accounting Off | F - Tax | $116.86 | -477 | 20.7K | -2% | -$55.7K | |
| 2026-07-07 16:09 | 2026-07-02 | INCY | Meury William | CEO, Dir, Pres | F - Tax | $116.86 | -4,779 | 156.3K | -3% | -$558.5K | |
| 2026-07-07 16:09 | 2026-07-02 | INCY | Stein Steven H | CMO, Head of Late-Stage Dev | F - Tax | $116.86 | -2,177 | 76.2K | -3% | -$254.4K | |
| MI | 2026-07-02 16:31 | 2026-06-30 | INCY | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +800 | 28.21M | +0.0% | $0 |
| 2026-07-02 16:08 | 2026-06-30 | INCY | Clancy Paul J | Dir | A - Grant | $113.36 | +252 | 25.6K | +1.0% | +$28.6K | |
| 2026-07-02 16:07 | 2026-06-30 | INCY | HARRIGAN EDMUND | Dir | A - Grant | $113.36 | +255 | 23.0K | +1% | +$28.9K | |
| DMI | 2026-06-10 16:41 | 2026-06-08 | INCY | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +3,284 | 28.21M | +0.0% | $0 |
| D | 2026-06-10 16:08 | 2026-06-08 | INCY | HARRIGAN EDMUND | Dir | A - Grant | $0.00 | +1,642 | 22.8K | +8% | $0 |
| D | 2026-06-10 16:07 | 2026-06-08 | INCY | Clancy Paul J | Dir | A - Grant | $0.00 | +1,642 | 25.4K | +7% | $0 |
| D | 2026-06-10 16:07 | 2026-06-08 | INCY | FOUSE JACQUALYN A | Dir | A - Grant | $0.00 | +1,642 | 21.0K | +8% | $0 |
| D | 2026-06-10 16:06 | 2026-06-08 | INCY | BIENAIME JEAN JACQUES | Dir | A - Grant | $0.00 | +1,642 | 24.4K | +7% | $0 |
| D | 2026-06-10 16:05 | 2026-06-08 | INCY | High Katherine A | Dir | A - Grant | $0.00 | +1,642 | 15.0K | +12% | $0 |
| D | 2026-06-10 16:05 | 2026-06-08 | INCY | BRAWLEY OTIS W | Dir | A - Grant | $0.00 | +1,642 | 12.9K | +15% | $0 |
| DT | 2026-06-08 16:04 | 2026-06-04 | INCY | Tray Thomas | Principal Accounting Off | M - OptEx | $83.83 | +2,639 | 23.8K | +12% | +$221.2K |
| DT | 2026-06-08 16:04 | 2026-06-04 | INCY | Tray Thomas | Principal Accounting Off | S - Sale+OE | $100.00 | -2,639 | 21.1K | -11% | -$263.9K |
| 2026-06-03 16:58 | 2026-06-01 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | F - Tax | $95.59 | -25.5K | 240.8K | -10% | -$2.43M | |
| T | 2026-05-28 16:03 | 2026-05-26 | INCY | Tray Thomas | Principal Accounting Off | S - Sale | $97.35 | -2,051 | 21.1K | -9% | -$199.7K |
| DT | 2026-05-28 16:03 | 2026-05-26 | INCY | BIENAIME JEAN JACQUES | Dir | M - OptEx | $84.53 | +15.0K | 35.8K | +72% | +$1.27M |
| DT | 2026-05-28 16:03 | 2026-05-26 | INCY | BIENAIME JEAN JACQUES | Dir | F - Tax | $97.10 | -13.1K | 22.8K | -36% | -$1.27M |
| DT | 2026-05-21 16:02 | 2026-05-19 | INCY | Clancy Paul J | Dir | M - OptEx | $84.53 | +15.0K | 38.7K | +63% | +$1.27M |
| DT | 2026-05-21 16:02 | 2026-05-19 | INCY | Clancy Paul J | Dir | S - Sale+OE | $94.93 | -15.0K | 23.7K | -39% | -$1.42M |
| A | 2026-05-20 16:02 | 2026-05-06 | INCY | Stein Steven H | CMO, Head of Late-Stage Dev | A - Grant | $0.00 | +44.1K | 78.3K | +129% | $0 |
| A | 2026-05-20 16:01 | 2026-05-06 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | A - Grant | $0.00 | +31.5K | 266.3K | +13% | $0 |
| DMI | 2026-05-11 16:45 | 2026-05-08 | INCY | BAKER BROS. ADVISORS LP | Dir, 10% | M - OptEx | $84.53 | +30.0K | 28.20M | +0.1% | +$2.54M |
| D | 2026-05-06 16:34 | 2026-05-04 | INCY | Upadhyay Suketu | EVP, CFO | A - Grant | $0.00 | +26.3K | 26.3K | New | $0 |
| DMT | 2026-04-21 16:09 | 2026-04-17 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | M - OptEx | $69.43 | +18.7K | 281.4K | +7% | +$1.30M |
| DT | 2026-04-21 16:09 | 2026-04-17 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | S - Sale+OE | $96.50 | -18.7K | 262.7K | -7% | -$1.80M |
| 2026-04-17 16:13 | 2026-04-15 | INCY | Meury William | CEO, Dir, Pres | M - OptEx | $0.00 | +125.0K | 161.1K | +346% | $0 | |
| 2026-04-17 16:12 | 2026-04-15 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | A - Grant | $0.00 | +27.9K | 262.7K | +12% | $0 | |
| 2026-04-17 16:12 | 2026-04-15 | INCY | Stein Steven H | CMO, Head of Late-Stage Dev | A - Grant | $0.00 | +39.0K | 73.3K | +114% | $0 | |
| MI | 2026-04-02 16:10 | 2026-03-31 | INCY | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +842 | 28.19M | +0.0% | $0 |
| 2026-04-02 16:10 | 2026-03-31 | INCY | HARRIGAN EDMUND | Dir | A - Grant | $94.12 | +269 | 21.1K | +1% | +$25.3K | |
| 2026-04-02 16:09 | 2026-03-31 | INCY | Clancy Paul J | Dir | A - Grant | $94.12 | +265 | 23.7K | +1% | +$24.9K | |
| 2026-03-26 | 2026-03-25 | INCY | Trotta Matteo | EVP, GM, Dermatology US | F - Tax | $92.23 | -537 | 14.9K | -3% | -$49.5K | |
| DM | 2026-03-19 | 2026-03-17 | INCY | CAGNONI PABLO J | Pres, R, D | M - OptEx | $63.07 | +18.7K | 242.0K | +8% | +$1.18M |
| D | 2026-03-19 | 2026-03-17 | INCY | CAGNONI PABLO J | Pres, R, D | S - Sale+OE | $94.24 | -18.7K | 234.8K | -7% | -$1.76M |
| DM | 2026-02-23 | 2026-02-19 | INCY | CAGNONI PABLO J | Pres, R, D | M - OptEx | $61.59 | +18.7K | 247.9K | +8% | +$1.15M |
| D | 2026-02-23 | 2026-02-19 | INCY | CAGNONI PABLO J | Pres, R, D | S - Sale+OE | $100.91 | -18.7K | 234.8K | -7% | -$1.88M |
| 2026-02-04 | 2026-02-02 | INCY | Morrissey Michael James | EVP, Head of Tech. Ops | F - Tax | $102.67 | -185 | 34.1K | -0.5% | -$19.0K | |
| 2026-02-04 | 2026-02-02 | INCY | Heeson Lee | EVP, Head of Incyte Intl | F - Tax | $102.67 | -111 | 38.0K | -0.3% | -$11.4K | |
| 2026-01-21 | 2026-01-16 | INCY | Morrissey Michael James | EVP, Head of Tech. Ops | A - Grant | $0.00 | +7,426 | 34.7K | +27% | $0 | |
| 2026-01-21 | 2026-01-20 | INCY | Morrissey Michael James | EVP, Head of Tech. Ops | F - Tax | $102.62 | -429 | 34.2K | -1% | -$44.0K | |
| 2026-01-21 | 2026-01-16 | INCY | Heeson Lee | EVP, Head of Incyte Intl | A - Grant | $0.00 | +8,911 | 38.2K | +30% | $0 | |
| 2026-01-08 | 2026-01-06 | INCY | Issa Mohamed Khairie | EVP, Head of US Oncology | F - Tax | $106.66 | -8,264 | 77.0K | -10% | -$881.4K | |
| 2026-01-08 | 2026-01-07 | INCY | Issa Mohamed Khairie | EVP, Head of US Oncology | S - Sale | $109.07 | -10.9K | 66.1K | -14% | -$1.18M | |
| 2026-01-07 | 2026-01-05 | INCY | Stein Steven H | EVP, Chief Medical Off | S - Sale | $101.70 | -15.6K | 34.2K | -31% | -$1.59M | |
| 2026-01-05 | 2025-12-31 | INCY | Clancy Paul J | Dir | A - Grant | $98.77 | +241 | 23.5K | +1% | +$23.8K | |
| 2026-01-05 | 2025-12-31 | INCY | HARRIGAN EDMUND | Dir | A - Grant | $98.77 | +245 | 20.9K | +1% | +$24.2K | |
| MI | 2026-01-05 | 2025-12-31 | INCY | BAKER FELIX | Dir, 10% | A - Grant | $0.00 | +656 | 28.19M | +0.0% | $0 |
| 2026-01-05 | 2025-12-31 | INCY | Morrissey Michael James | EVP, Head of Tech. Ops | F - Tax | $98.77 | -254 | 27.3K | -0.9% | -$25.1K | |
| 2026-01-05 | 2025-12-31 | INCY | Stein Steven H | EVP, Chief Medical Off | F - Tax | $98.77 | -13.3K | 49.8K | -21% | -$1.31M | |
| DM | 2025-12-22 | 2025-12-19 | INCY | Tray Thomas | Principal Accounting Off | M - OptEx | $95.76 | +2,774 | 25.7K | +12% | +$265.6K |
| DM | 2025-12-22 | 2025-12-18+ | INCY | Tray Thomas | Principal Accounting Off | S - Sale+OE | $99.69 | -3,374 | 23.0K | -13% | -$336.4K |
| M | 2025-12-18 | 2025-12-16+ | INCY | Morrissey Michael James | EVP, Head of Tech. Ops | S - Sale | $97.29 | -58.3K | 27.5K | -68% | -$5.68M |
| M | 2025-12-12 | 2025-12-10+ | INCY | Mayes Patrick A | EVP, CSO | S - Sale | $95.55 | -5,808 | 60.3K | -9% | -$555.0K |
| 2025-12-10 | 2025-12-08 | INCY | Hoppenot Herve | Dir | F - Tax | $96.70 | -2,843 | 326.8K | -0.9% | -$274.9K | |
| D | 2025-12-03 | 2025-12-01 | INCY | Hoffman Richard A. | EVP, GC | A - Grant | $0.00 | +9,466 | 9,466 | New | $0 |
| M | 2025-12-03 | 2025-12-01+ | INCY | Stein Steven H | EVP, Chief Medical Off | S - Sale | $102.56 | -22.7K | 63.1K | -26% | -$2.32M |
| 2025-12-03 | 2025-12-01 | INCY | Stein Steven H | EVP, Chief Medical Off | F - Tax | $102.04 | -17.1K | 83.2K | -17% | -$1.74M | |
| 2025-12-03 | 2025-12-01 | INCY | Morrissey Michael James | EVP, Head of Tech. Ops | F - Tax | $102.04 | -326 | 85.8K | -0.4% | -$33.3K | |
| M | 2025-11-25 | 2025-11-21+ | INCY | Tray Thomas | Principal Accounting Off | S - Sale | $102.78 | -769 | 23.6K | -3% | -$79.0K |
| D | 2025-11-19 | 2025-11-17 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $64.25 | +278 | 26.8K | +1% | +$17.9K |
| D | 2025-11-19 | 2025-11-17 | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $104.36 | -278 | 26.6K | -1% | -$29.0K |
| 2025-11-12 | 2025-11-10 | INCY | Hoppenot Herve | Dir | S - Sale | $105.46 | -187.5K | 329.6K | -36% | -$19.77M | |
| D | 2025-11-07 | 2025-11-05 | INCY | Stein Steven H | EVP, Chief Medical Off | S - Sale+OE | $102.20 | -5,233 | 102.9K | -5% | -$534.8K |
| DM | 2025-11-07 | 2025-11-05 | INCY | Stein Steven H | EVP, Chief Medical Off | M - OptEx | $93.04 | +5,233 | 108.1K | +5% | +$486.9K |
| D | 2025-11-06 | 2025-11-04 | INCY | Denton Sheila A. | EVP, GC | M - OptEx | $58.06 | +598 | 27.2K | +2% | +$34.7K |
| D | 2025-11-06 | 2025-11-04 | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $101.36 | -598 | 26.6K | -2% | -$60.6K |
| 2025-11-05 | 2025-11-03 | INCY | Heeson Lee | EVP, Head of Incyte Intl | S - Sale | $94.02 | -3,074 | 29.2K | -10% | -$289.0K | |
| D | 2025-10-17 | 2025-10-15 | INCY | Denton Sheila A. | EVP, GC | S - Sale+OE | $85.13 | -277 | 26.6K | -1% | -$23.6K |
Purchase Sale Sale after option exercise All abbreviations